All Updates

All Updates

icon
Filter
Partnerships
Gandeeva enters cryo-EM research collaboration with Moderna
AI Drug Discovery
Mar 30, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
AI Drug Discovery

AI Drug Discovery

Mar 30, 2023

Gandeeva enters cryo-EM research collaboration with Moderna

Partnerships

  • AI-driven precision biotechnology company Gandeeva Therapeutics has entered a research collaboration with biotechnology company Moderna to explore how Gandeeva’s technology platform can be utilized in one of Moderna’s programs.

  • Under the terms of the agreement, both companies will work together to study and validate the application of Gandeeva's proprietary cryogenic electron microscopy (cryo-EM) platform approach for a Moderna target. Further, Gandeeva will receive research payments from Moderna. 

  • Canadian AI precision company Gandeeva Therapeutics develops precision medicines by leveraging AI/ML, structural biology, biochemistry, and imaging technologies. It follows the cryogenic electron microscopy (cryo-EM) approach that captures detailed images of proteins to determine their structures to the level as small as two angstroms (one-tenth of a nanometer) and zoom in on specific areas of a protein, thereby providing insights to accelerate the drug discovery process.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.